[1] |
GUO Ningzi, LIU Li, YUE Ruiqi, FENG Huiqing, YANG Huaxin, WEI Ningyi, CHEN Hua.
Determination of particle size distribution of chiglitazar sodium by laser diffraction method
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 147-151.
|
[2] |
XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue.
285 cases of adverse drug reaction related to new antineoplastic drugs
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203.
|
[3] |
JIN Shengju, ZHOU Miao, ZHANG Jianing, GE Gonghui, ZHANG Tingjian, MENG Fanhao.
Research progress in novel xanthine oxidase inhibitors and treatment of gout
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 223-228.
|
[4] |
JIANG Wenshuo, YANG Li.
Adverse drug reaction among 694 patients in an epilepsy physician-pharmacist joint clinic
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 102-106.
|
[5] |
GAO Xu, PENG Jin’e, LI Xingwang, ZHANG Wei.
Recent research of antiviral drugs and vaccines for Mpox
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 111-116.
|
[6] |
MA Ruize, CHEN Zhihai.
The latest progress of small molecule anti-SARS-CoV-2 drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 961-966.
|
[7] |
HUANG Jinjian, ZHANG Xiaomeng, ZHANG Bing, DING Xueli, YANG Ying, LIN Zhijian.
Cardiovascular risk signaling mining and mechanism of uric acid-lowering drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 866-871.
|
[8] |
SHI Xiangfen, SUN Zhiyong, ZHANG Xufeng, LU Xiaojing, DU Shuzhang, ZHANG Xiaojian.
Whole process management of narcotic drugs and psychotropic drugs based on intelligent information management system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 899-903.
|
[9] |
YAN Yishu, ZHAO Yan, LU Tiangong, SUN Zhenxiao.
Emodin -8-O-β-D-glucoside combined with paclitaxel inhibits the viability and metastasis of human breast cancer cells
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 728-734.
|
[10] |
LIU Jing, XIA Liang, ZHANG Shijie.
Pharmaceutical care of a patient with acute pancreatitis complicated with multiple drug allergy undergoing drug stimulation test
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 822-824.
|
[11] |
LI Tan, ZHANG Yang, ZHANG Wangde, WANG Yun.
Efficacy and safety of different analgesia drugs in the treatment of lower extremity ischemic pain
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 680-683.
|
[12] |
ZHAO Xuan, GUO Jing, CHEN Ning, MEI Long, ZHENG Tingting, ZHANG Lifang, ZHANG Wei.
Discuss the safety management of medical toxic drugs in medical institutions
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 705-708.
|
[13] |
CHENG Fengjingming, LYU Jian, XIE Yanming.
Efficacy and safety of compound salvia miltiorrhiza spray/aerosol for angina pectoris due to coronary artery disease: a Meta analysis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 536-543.
|
[14] |
HUO Peiqiong, ZHENG Peng, SU Zhenhao.
Pharmacovigilance in retail pharmacies for special or major diseases
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 428-432.
|
[15] |
CHEN Cheng, DENG Li, LIU Songqing, DU Qian, XI Xin.
Analysis of reports of allergic shock in Chongqing between 2015 and 2020
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 460-464.
|